Smoldering multiple myeloma (SMM) is an asymptomatic precursor to multiple myeloma.
Here we define the epidemiological characteristics of SMM in the general population in …

Background Smoldering multiple myeloma (SMM), an asymptomatic precursor of multiple
myeloma (MM), carries a variable risk of progression to MM. There is little consensus on the …

The current standard of care in smoldering multiple myeloma (SMM) is close surveillance,
outside of clinical trials. Efforts are being made to understand the pathobiologic process that …

Background Smoldering myeloma (SMM) is an asymptomatic precursor condition to multiple
myeloma (MM) with a variable risk of progression. The management of high-risk SMM (HR …

Smoldering multiple myeloma (SMM) is an asymptomatic precursor condition to multiple
myeloma (MM). The prevalence of SMM is 0.5% in persons over 40 years old; it is higher in …

Smouldering multiple myeloma (SMM) is an asymptomatic clonal plasma cell disorder
meeting serological and morphological criterion of multiple myeloma (MM) but without …

Monoclonal antibodies (MoAbs) targeting several cellular receptors have significantly
improved the prognosis of multiple myeloma (MM). Their high effectiveness and safety raise …

The phenomenon of stage migration in cancers leads to apparent survival improvement in
both lower and higher stages. This is due to an upward migration of patients with adverse …

Smoldering multiple myeloma has been recognized for over 40 years and represents a pre-
symptomatic phase of the 2nd most common hematologic malignancy. 1/3 of patients will …

In this issue of Leukemia and Lymphoma, Mohyuddin and colleague examined the
characteristics of 32 clinical trials evaluating patients with smoldering multiple myeloma. In …